MustGrow Biologics Statistics
MustGrow Biologics (MGROF) Stock Statistics & Valuation Metrics
Total Valuation
MustGrow Biologics has a market cap or net worth of $20.20M. The enterprise value is $20.73M.
- Market Cap
- $20.20M
- Enterprise Value
- $20.73M
Share Statistics
MustGrow Biologics has 70,441,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 70,441,360
- Owned by Insiders
- 10.91%
- Owned by Institutions
- ―
Financial Efficiency
MustGrow Biologics’s return on equity (ROE) is -8.37 and return on invested capital (ROIC) is -430.85%.
- Return on Equity (ROE)
- -8.37
- Return on Assets (ROA)
- -2.35
- Return on Invested Capital (ROIC)
- -430.85%
- Return on Capital Employed (ROCE)
- -6.14
- Revenue Per Employee
- 1.04M
- Profits Per Employee
- -907.21K
- Employee Count
- 8
- Asset Turnover
- 2.68
- Inventory Turnover
- 3.44
Valuation Ratios
The current PE Ratio of MustGrow Biologics is -4.23. MustGrow Biologics’s PEG ratio is -0.61.
- PE Ratio
- -4.23
- PS Ratio
- 9.04
- PB Ratio
- 5.19
- Price to FCF
- -6.66
- Price to Operating Cash Flow
- -9.20
- PEG Ratio
- -0.61
Income Statement
In the last 12 months, MustGrow Biologics had revenue of 8.29M and earned -7.26M in profits. Earnings per share was -0.13.
- Revenue
- 8.29M
- Gross Profit
- 1.41M
- Operating Income
- -6.25M
- Pretax Income
- -7.26M
- Net Income
- -7.26M
- EBITDA
- -6.20M
- Earnings Per Share (EPS)
- -0.13
Cash Flow
In the last 12 months, operating cash flow was -2.85M and capital expenditures -1.49M, giving a free cash flow of -4.34M billion.
- Operating Cash Flow
- -2.85M
- Free Cash Flow
- -4.34M
- Free Cash Flow per Share
- -0.07
Dividends & Yields
MustGrow Biologics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.02%
- Earnings Yield
- -21.26%
Stock Price Statistics
- Beta
- 0.21
- 52-Week Price Change
- -40.91%
- 50-Day Moving Average
- 0.29
- 200-Day Moving Average
- 0.35
- Relative Strength Index (RSI)
- 53.47
- Average Volume (3m)
- 4,825
Important Dates
MustGrow Biologics upcoming earnings date is Dec 01, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Dec 01, 2026
- Ex-Dividend Date
- ―
Financial Position
MustGrow Biologics as a current ratio of 1.48, with Debt / Equity ratio of 67.37%
- Current Ratio
- 1.48
- Quick Ratio
- 0.51
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.05
- Interest Coverage Ratio
- -19.97
Taxes
In the past 12 months, MustGrow Biologics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
MustGrow Biologics EV to EBITDA ratio is -5.95, with an EV/FCF ratio of -5.77.
- EV to Sales
- 7.83
- EV to EBITDA
- -5.95
- EV to Free Cash Flow
- -5.77
- EV to Operating Cash Flow
- -8.78
Balance Sheet
MustGrow Biologics has $4.37M in cash and marketable securities with $515.57K in debt, giving a net cash position of $3.86M billion.
- Cash & Marketable Securities
- $4.37M
- Total Debt
- $515.57K
- Net Cash
- $3.86M
- Net Cash Per Share
- $0.05
- Tangible Book Value Per Share
- $0.08
Margins
Gross margin is 52.78%, with operating margin of -132.57%, and net profit margin of -174.40%.
- Gross Margin
- 52.78%
- Operating Margin
- -132.57%
- Pretax Margin
- -156.24%
- Net Profit Margin
- -174.40%
- EBITDA Margin
- -131.69%
- EBIT Margin
- -132.52%
Analyst Forecast
The average price target for MustGrow Biologics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -53.75%
- EPS Growth Forecast
- 9.88%
